Back to results
CompletedPhase 3

Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients

NCT00957203

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Tokyo, Japan

View on ClinicalTrials.gov
Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients — TrialFind